Microsoft Corp. (MSFT) Shareholder Weik Investment Services Has Trimmed Position by $477,660; Callahan Advisors Stake in Celgene (CELG) Has Increased by $2.71 Million

Celgene Corporation (NASDAQ:CELG) Logo

Weik Investment Services Inc decreased its stake in Microsoft Corp. (MSFT) by 4.07% based on its latest 2018Q3 regulatory filing with the SEC. Weik Investment Services Inc sold 4,190 shares as the company’s stock declined 1.64% with the market. The institutional investor held 98,665 shares of the prepackaged software company at the end of 2018Q3, valued at $11.28M, down from 102,855 at the end of the previous reported quarter. Weik Investment Services Inc who had been investing in Microsoft Corp. for a number of months, seems to be less bullish one the $807.50 billion market cap company. The stock decreased 0.40% or $0.42 during the last trading session, reaching $105.25. About 18.12 million shares traded. Microsoft Corporation (NASDAQ:MSFT) has risen 30.43% since February 11, 2018 and is uptrending. It has outperformed by 30.43% the S&P500. Some Historical MSFT News: 09/04/2018 – In the Face of DFARS Pressures – Microsoft Gold Partner Launching Managed IT Support Service Uniquely Suited for Federal Contractors; 26/04/2018 – MSFT: COMMERCIAL CLOUD SERVICE GROSS MARGIN TO IMPROVE IN FY19; 16/05/2018 – Regina Leader: Microsoft planning low-cost Surface tablet line to take on iPad; 26/04/2018 – Gamida Cell Strengthens Leadership Team with Appointments of Josh Hamermesh as Chief Business Officer and Paul Nee as Vice President of Marketing; 26/04/2018 – MICROSOFT 3Q INTELLIGENT CLOUD REV. $7.90B; 22/05/2018 – Epicor to Accelerate Cloud ERP Adoption and Bring the Intelligent Cloud to Manufacturers and Distributors via Microsoft Azure; 14/05/2018 – PROS Named as Inaugural Manufacturing Partner in Global Microsoft Technology Centers; 15/05/2018 – Valueact Adds SLM, Exits Microsoft, Cuts Armstrong World: 13F; 07/05/2018 – Berkshire Hathaway CEO Warren Buffett called bitcoin “probably rat poison squared,” Berkshire Chairman Charlie Munger said trading in cryptocurrencies is “just dementia,” and Microsoft co-founder Bill Gates told CNBC that he would bet against bitcoin if he could; 26/04/2018 – MICROSOFT CLIMBS AFTER GIVING 4Q REVENUE FORECAST ON CALL

Callahan Advisors Llc increased its stake in Celgene Corp (CELG) by 765.95% based on its latest 2018Q3 regulatory filing with the SEC. Callahan Advisors Llc bought 30,485 shares as the company’s stock declined 22.96% with the market. The institutional investor held 34,465 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $3.08M, up from 3,980 at the end of the previous reported quarter. Callahan Advisors Llc who had been investing in Celgene Corp for a number of months, seems to be bullish on the $62.93 billion market cap company. The stock increased 2.23% or $1.96 during the last trading session, reaching $89.87. About 10.79 million shares traded or 4.83% up from the average. Celgene Corporation (NASDAQ:CELG) has declined 33.15% since February 11, 2018 and is downtrending. It has underperformed by 33.15% the S&P500. Some Historical CELG News: 19/04/2018 – Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Celgene Corporation (CELG) and; 04/05/2018 – CELGENE 1Q ADJ EPS $2.05, EST. $1.96; 13/03/2018 – Genentech’s Ocrevus Begins to Move the Needle on the Treatment Rate for Primary Progressive Multiple Sclerosis but May Not Be the Only Disease-Modifying Therapy in Play; 23/04/2018 – Zymeworks and Celgene Expand Bispecific Antibody Collaboration; 28/03/2018 – BLUEBIRD BIO-CELGENE TO CO-DEVELOP ANTI-BCMA CAR T CELL THERAPY; 10/05/2018 – Denali Therapeutics Closes Above 50-Day Moving Average; 16/04/2018 – OPDIVO PLUS LOW-DOSE YERVOY COMBINATION REDUCES RISK OF PROGRES; 23/04/2018 – EUROPEAN MEDICINES AGENCY VALIDATES TYPE Il VARIATION FOR MERCK’S KEYTRUDA® (PEMBROLIZUMAB) IN COMBINATION WITH PEMETREXED (ALIMTA®) AND PLATINUM CHEMOTHERAPY AS FIRST-LINE THERAPY IN METASTATIC; 09/04/2018 – CELG: Celgene M&A targets may include Agios, Jounce, FT reports; 03/05/2018 – Kessler Topaz Meltzer & Check, LLP Announces Expanded Class Period in Securities Class Action Filed against Celgene Corporation

Among 38 analysts covering Microsoft Corporation (NASDAQ:MSFT), 34 have Buy rating, 1 Sell and 3 Hold. Therefore 89% are positive. Microsoft Corporation had 217 analyst reports since July 22, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Monday, September 25 by KeyBanc Capital Markets. Citigroup maintained Microsoft Corporation (NASDAQ:MSFT) rating on Thursday, October 25. Citigroup has “Neutral” rating and $114 target. The stock of Microsoft Corporation (NASDAQ:MSFT) has “Buy” rating given on Friday, June 8 by Morgan Stanley. The stock has “Buy” rating by Canaccord Genuity on Friday, April 27. UBS maintained Microsoft Corporation (NASDAQ:MSFT) on Friday, October 23 with “Buy” rating. As per Thursday, November 10, the company rating was upgraded by Atlantic Securities. The firm earned “Buy” rating on Thursday, February 1 by Cowen & Co. The rating was maintained by UBS on Wednesday, June 13 with “Buy”. The stock of Microsoft Corporation (NASDAQ:MSFT) earned “Hold” rating by Wunderlich on Wednesday, July 22. The stock of Microsoft Corporation (NASDAQ:MSFT) has “Outperform” rating given on Wednesday, July 20 by FBN Securities.

Weik Investment Services Inc, which manages about $228.44 million and $208.47M US Long portfolio, upped its stake in T (NYSE:TMUS) by 4,390 shares to 10,235 shares, valued at $718,000 in 2018Q3, according to the filing.

More notable recent Microsoft Corporation (NASDAQ:MSFT) news were published by: Seekingalpha.com which released: “Why I Sold Microsoft February Puts – Seeking Alpha” on January 24, 2019, also Investorplace.com with their article: “5 Top Stock Trades for Friday: MSFT, FB, PYPL, V – Investorplace.com” published on January 31, 2019, Nasdaq.com published: “After Hours Most Active for Jan 30, 2019 : CZR, FB, MSFT, AMD, MO, INTC, MCHI, LVS, F, BAC, TAK, BABA – Nasdaq” on January 30, 2019. More interesting news about Microsoft Corporation (NASDAQ:MSFT) were released by: Nasdaq.com and their article: “Technology Sector Update for 02/06/2019: ARLO, SNAP, TTWO, MSFT, AAPL, CSCO, IBM, GOOG – Nasdaq” published on February 06, 2019 as well as Nasdaq.com‘s news article titled: “Microsoft Secures $1.76B Contract From Defense Department – Nasdaq” with publication date: January 14, 2019.

Since August 31, 2018, it had 0 buys, and 11 sales for $82.43 million activity. Hood Amy sold $13.09M worth of Microsoft Corporation (NASDAQ:MSFT) on Friday, August 31. Hogan Kathleen T also sold $4.45 million worth of Microsoft Corporation (NASDAQ:MSFT) on Friday, August 31. $214,363 worth of Microsoft Corporation (NASDAQ:MSFT) was sold by BROD FRANK H. Nadella Satya also sold $28.35 million worth of Microsoft Corporation (NASDAQ:MSFT) shares.

Investors sentiment decreased to 0.81 in 2018 Q3. Its down 0.03, from 0.84 in 2018Q2. It fall, as 33 investors sold MSFT shares while 981 reduced holdings. 145 funds opened positions while 681 raised stakes. 5.28 billion shares or 0.60% less from 5.31 billion shares in 2018Q2 were reported. Saratoga Rech Invest Mngmt holds 800,281 shares. Ghp Advisors reported 1.14% stake. Armstrong Shaw Assoc Inc Ct stated it has 6.42% in Microsoft Corporation (NASDAQ:MSFT). Hengehold Cap Ltd Liability Corporation reported 26,792 shares or 0.77% of all its holdings. Woodmont Invest Counsel Limited Company reported 1.97% in Microsoft Corporation (NASDAQ:MSFT). Brandes Investment Prns Lp owns 360,050 shares for 0.93% of their portfolio. Hoertkorn Richard Charles invested 6.02% of its portfolio in Microsoft Corporation (NASDAQ:MSFT). Forbes J M And Communications Ltd Liability Partnership has invested 1.85% of its portfolio in Microsoft Corporation (NASDAQ:MSFT). Baker Avenue Asset Mngmt Lp holds 1.71% or 181,123 shares in its portfolio. Sphera Funds Mngmt Limited, Israel-based fund reported 69,656 shares. Pathstone Family Office Limited has 0.06% invested in Microsoft Corporation (NASDAQ:MSFT) for 1,570 shares. Mount Vernon Associates Md reported 28,355 shares or 4.78% of all its holdings. Northstar Grp Inc Inc stated it has 5,865 shares. Everett Harris & Ca reported 1.60 million shares stake. Fenimore Asset Management Incorporated has invested 0.03% of its portfolio in Microsoft Corporation (NASDAQ:MSFT).

Among 35 analysts covering Celgene Corporation (NASDAQ:CELG), 22 have Buy rating, 0 Sell and 13 Hold. Therefore 63% are positive. Celgene Corporation had 161 analyst reports since July 21, 2015 according to SRatingsIntel. Stifel Nicolaus maintained the shares of CELG in report on Friday, July 28 with “Buy” rating. On Friday, January 4 the stock rating was upgraded by Goldman Sachs to “Neutral”. As per Tuesday, January 23, the company rating was maintained by RBC Capital Markets. The stock has “Buy” rating by RBC Capital Markets on Wednesday, October 4. The stock has “Buy” rating by Oppenheimer on Thursday, July 27. SunTrust maintained Celgene Corporation (NASDAQ:CELG) on Monday, January 8 with “Buy” rating. The firm earned “Buy” rating on Monday, January 8 by BMO Capital Markets. Citigroup downgraded the shares of CELG in report on Friday, October 20 to “Hold” rating. As per Tuesday, April 19, the company rating was maintained by Credit Suisse. The firm has “Equal-Weight” rating given on Friday, July 13 by Morgan Stanley.

More notable recent Celgene Corporation (NASDAQ:CELG) news were published by: Nasdaq.com which released: “3 Biotech Stocks Flashing ‘Buy Me!’ – Nasdaq” on January 16, 2019, also Seekingalpha.com with their article: “Bristol-Myers gets two-notch upgrade post-Celgene deal – Seeking Alpha” published on January 15, 2019, Nasdaq.com published: “Pre-Market Most Active for Feb 4, 2019 : IMGN, FOLD, ODP, UNM, PSX, XOG, MTOR, ELY, ACB, BC, EOLS, CELG – Nasdaq” on February 04, 2019. More interesting news about Celgene Corporation (NASDAQ:CELG) were released by: Nasdaq.com and their article: “Biotech Stock Roundup: Celgene Tops in Q4, Gilead Disappoints, ALKS & AVEO Sink – Nasdaq” published on February 06, 2019 as well as Seekingalpha.com‘s news article titled: “Celgene teams up with Kyn Therapeutics in cancer – Seeking Alpha” with publication date: January 18, 2019.

Celgene Corporation (NASDAQ:CELG) Institutional Positions Chart